Last10K.com

Hutchison China Meditech Ltd (HCM) SEC Filing 20-F Annual report for the fiscal year ending Tuesday, December 31, 2019

Hutchison China Meditech Ltd

CIK: 1648257 Ticker: HCM

View differences made from one year to another to evaluate Hutchison China Meditech Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Hutchison China Meditech Ltd.

Continue

Assess how Hutchison China Meditech Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Hutchison China Meditech Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity
Consolidated Statements Of Comprehensive Loss
Consolidated Statements Of Operations
Accounts Payable
Accounts Payable (Details)
Accounts Payable (Tables)
Accounts Receivable-Third Parties
Accounts Receivable-Third Parties (Details)
Accounts Receivable-Third Parties (Tables)
Accounts Receivable-Third Parties - Movements On The Allowance For Doubtful Accounts Receivable (Details)
Bank Borrowings
Bank Borrowings (Tables)
Bank Borrowings - Loan Facilities (Details)
Bank Borrowings - Schedule Of Bank Borrowings (Details)
Bank Borrowings - Schedule Of Maturities Of Bank Borrowings (Details)
Cash And Cash Equivalents
Cash And Cash Equivalents (Details)
Cash And Cash Equivalents (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Commitments And Contingencies (Tables)
Fair Value Disclosures
Fair Value Disclosures (Details)
Fair Value Disclosures (Tables)
Government Incentives
Government Incentives (Details)
Government Incentives (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Income Taxes - Income Tax Payable (Details)
Income Taxes - Movements In Deferred Tax Assets And Liabilities (Details)
Income Taxes - Significant Components Of Deferred Tax Assets And Liabilities (Details)
Income Taxes - Tax Losses Carryforwards And Deferred Tax Valuation Allowance (Details)
Inventories
Inventories (Details)
Inventories (Tables)
Investments In Equity Investees
Investments In Equity Investees (Details)
Investments In Equity Investees (Tables)
Investments In Equity Investees - Capital Commitments (Details)
Investments In Equity Investees - Reconciliation Of Summarized Financial Information (Details)
Investments In Equity Investees - Summarized Balance Sheets (Details)
Investments In Equity Investees - Summarized Statements Of Operations (Details)
Leases
Leases (Details)
Leases (Tables)
Litigation
Litigation (Details)
Losses Per Share
Losses Per Share (Details)
Losses Per Share (Tables)
Note To Consolidated Statements Of Cash Flows
Note To Consolidated Statements Of Cash Flows (Details)
Note To Consolidated Statements Of Cash Flows (Tables)
Ordinary Shares
Ordinary Shares (Details)
Ordinary Shares (Tables)
Organization And Nature Of Business
Organization And Nature Of Business (Details)
Other Payables, Accruals And Advance Receipts
Other Payables, Accruals And Advance Receipts (Details)
Other Payables, Accruals And Advance Receipts (Tables)
Other Receivables, Prepayments And Deposits
Other Receivables, Prepayments And Deposits (Details)
Other Receivables, Prepayments And Deposits (Tables)
Particulars Of Principal Subsidiaries And Equity Investees
Particulars Of Principal Subsidiaries And Equity Investees (Details)
Particulars Of Principal Subsidiaries And Equity Investees (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Tables)
Research And Development Expenses
Research And Development Expenses (Details)
Research And Development Expenses (Tables)
Restricted Net Assets
Restricted Net Assets (Details)
Revenues
Revenues (Details)
Revenues (Tables)
Revenues - Balances From Contract With Customers And Estimated Deferred Revenue To Be Recognized (Details)
Revenues - License And Collaboration Agreement (Details)
Segment Reporting
Segment Reporting (Tables)
Segment Reporting - Elimination (Details)
Segment Reporting - Reconciliation Of Operating Loss To Net Loss (Details)
Segment Reporting - Segment Information (Details)
Share Based Compensation - Hcml Share Option Scheme (Details)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - Hcml Options Fair Value Assumptions (Details)
Share-Based Compensation - Hcml Share Based Compensation Expense (Details)
Share-Based Compensation - Hcml Share Option Activity (Details)
Share-Based Compensation - Hcml Share Option Exercises (Details)
Share-Based Compensation - Ltip (Details)
Share-Based Compensation - Ltip Share Based Compensation Expense (Details)
Short-Term Investments
Short-Term Investments (Details)
Short-Term Investments (Tables)
Significant Transactions With Related Parties And Non-Controlling Shareholders Of Subsidiaries
Significant Transactions With Related Parties And Non-Controlling Shareholders Of Subsidiaries (Tables)
Significant Transactions With Related Parties And Non-Controlling Shareholders Of Subsidiaries - Non-Controlling Shareholders Of Subsidiaries (Details)
Significant Transactions With Related Parties And Non-Controlling Shareholders Of Subsidiaries - Related Parties (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Leases (Details)
Summary Of Significant Accounting Policies - Profit Appropriation And Statutory Reserves (Details)
Summary Of Significant Accounting Policies - Revenue Recognition (Details)
Ticker: HCM
CIK: 1648257
Form Type: 20-F Annual Report
Accession Number: 0001104659-20-028220
Submitted to the SEC: Tue Mar 03 2020 7:33:08 AM EST
Accepted by the SEC: Tue Mar 03 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/hcm/0001104659-20-028220.htm